Global neurostimulation devices market size is expected to grow from USD 2.03 bn in 2024 to USD 2.24 bn in 2025 and USD 6.08 bn by 2035, at a CAGR of 11%

The Neurostimulation Devices Market report segments the industry into By Device Type (Implantable Devices, External Devices), By Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, Other Applications), By End-Users (Clinics, Hospitals, Rehabilitation Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

The global neurostimulation devices market in 2018 stood at some 6.8 billion U.S. dollars. By 2024, the market is projected to increase to some 12 billion dollars. Among the best known neurostimulation devices are, for example, spinal cord stimulation devices, auditory brainstem implants, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, and non-implantable devices.

According to Cognitive Market Research, the global Neurostimulation Devices market size will be USD 8740 million in 2025. It will expand at a compound annual growth rate (CAGR) of 13.40% from 2025 to 2033.

North America held the major market share for more than 40% of the global revenue with a market size of USD 3233.80 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2534.60 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 2097.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 16.3% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 332.12 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.1% from 2025 to 2033.
The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 349.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 14.8% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 192.28 million in 2025. and will grow at a compound annual growth rate (CAGR) of 13.7% from 2025 to 2033.
The spinal cord stimulator category is the fastest growing segment of the Neurostimulation Devices industry

Market Dynamics of Neurostimulation Devices Market

Key Drivers for Neurostimulation Devices Market

Rising prevalence of neurological disorders will drive the growth of neurostimulation device market

The neurostimulation devices market worldwide is growing at a rapid pace with increasing neurological disorders. The increased incidence of chronic pain, epilepsy, Parkinson's disease, and depression drives demand for neurostimulation devices for treatment. Neurological disorders are increasingly prevalent all over the world, affecting a large percentage of the population. For instance, over 3 billion individuals around the globe suffered from a neurological disorder in 2021. https://www.who.int/news/item/14-03-2024-over-1-in-3-people-affected-by-neurological-conditions--the-leading-cause-of-illness-and-disability-worldwide Parkinson's disease is a neurodegenerative disorder that occurs with ageing and is found in a large population of individuals worldwide. It is caused by muscles contraction, which weakens body movement, tremors, muscle rigidity, and gait. Parkinson's disease can involve more than one system of the body. For instance, the Parkinson's Foundation reports over 10 million individuals with Parkinson’s disease worldwide. Nearly one million people in the U.S. live with Parkinson's disease. As many as about 90,000 people are estimated to receive a diagnosis for Parkinson's disease annually in the U.S. https://www.parkinson.org/understanding-parkinsons/statistics Neurostimulation devices, which apply electrical impulses to the nervous system, are finding more applications in the management of pain, enhancement of function, and treatment of other neurological disorders. The market for neurostimulation devices is witnessing sharp growth, owing to increasing neurological disorders. The increase in diseases such as chronic pain, epilepsy, Parkinson's disease, and depression drives demand for neurostimulation devices as treatment. Neurological disorders are increasingly prevalent around the world and are affecting a large segment of the population. Therefore, the rising prevalence of neurological disorders will drive the growth of neurostimulation device market.

Improved miniaturization and wireless capabilities boost adoption To Boost Market Growth

The improved miniaturization and wireless capabilities of digital migraine treatment devices are key drivers boosting market growth. Advances in microelectronics and compact design have enabled more portable, user-friendly, and discreet devices, enhancing patient compliance. Wireless connectivity allows seamless integration with mobile apps, enabling remote monitoring, data tracking, and personalized treatment plans. These innovations cater to the rising demand for non-invasive migraine relief, reducing dependency on pharmaceuticals. Additionally, the growing preference for wearable, home-use devices and increasing awareness about digital t...

The global neurostimulation devices market size reached USD 9.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

IMARC Group provides an analysis of the key trends in each segment of the global neurostimulation devices market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on stimulation type, device type, application, and end-user.

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

The global Neurostimulation Devices Market is anticipated to reach $18,033.0 Million by 2030, witnessing a CAGR of 8.87% during the forecast period 2021-2030.

The North America Neurostimulation Devices Market report segments the industry into By Device Type (Implantable Devices, External Devices), By Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, Other Applications), and Geography (United States, Canada, Mexico). The report includes five years of historical data and five-year forecasts.

The global neurostimulation devices market size was valued at over USD 11.32 billion in 2024 and is expected to expand at a CAGR of around 12.3%, surpassing USD 51.14 billion revenue by 2037. Hospitals segment is poised to account for majority share by 2037, fueled by growing healthcare infrastructure globally and the increasing incidence of chronic pain, with projected growth in the Indian healthcare market.

The global Neurostimulation Devices market size reached USD 7,830 33Million in 2021 and is expected to reach USD 21,326 37 Million in 2030 registering a CAGR of 12.0%. Neurostimulation Devices market growth is primarily driven owing to improvement in healthcare expenditure globally and rising geriat...

Snapshot img

Neurostimulation Devices Market Size 2024-2028

The neurostimulation devices market size is forecast to increase by USD 7.29 billion at a CAGR of 12.7% between 2023 and 2028.

The market is experiencing significant growth, driven by the rising prevalence of neurological disorders and expanding indications for neurostimulation devices. Neurological disorders, such as Parkinson's disease, epilepsy, and chronic pain, affect millions of people worldwide, creating a substantial demand for effective treatment options. Neurostimulation devices, which use electrical impulses to stimulate nerves and modify brain activity, offer promising solutions for managing these conditions. However, the market growth is not without challenges. The high cost of neurostimulation devices and procedures remains a significant barrier to widespread adoption. Despite these challenges, opportunities exist for companies to capitalize on market trends and navigate challenges effectively. For instance, developing cost-effective solutions through technological advancements and collaborations with healthcare providers could help make neurostimulation devices more accessible to patients. Additionally, expanding indications for neurostimulation devices into new therapeutic areas, such as mental health disorders, could open up new revenue streams and broaden the market scope. Overall, the market presents a compelling investment opportunity for companies seeking to innovate and address the unmet needs of patients with neurological disorders.

What will be the Size of the Neurostimulation Devices Market during the forecast period?

Request Free SampleThe market encompasses a range of implantable medical devices used to treat various neurological disorders. These devices, including spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, and sacral nerve stimulators, employ neuromodulation techniques to alleviate symptoms of conditions such as Parkinson's disease, dystonia, chronic pain, overactive bladder syndrome, and neurological injuries. Neurostimulation devices offer an alternative to traditional surgical treatments and drug therapies for managing neurological disorders. The market is experiencing significant growth due to the increasing prevalence of neurological diseases, such as Alzheimer's and stroke, and the rising demand for minimally invasive procedures. The market's expansion is also driven by advancements in technology, enabling the development of more effective and patient-friendly devices. Reimbursement policies and healthcare providers' growing acceptance of neurostimulation devices further contribute to the market's growth. Despite these positive trends, challenges remain, including regulatory requirements and the need for continuous innovation to address the diverse needs of patients.

How is this Neurostimulation Devices Industry segmented?

The neurostimulation devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductImplantable neurostimulation devicesExternal neurostimulation devicesApplicationPain managementUrinary and fecal incontinenceParkinson's diseaseEpilepsyMovement disordersChronic migrainesOthersTypeInvasiveNon-InvasiveGeographyNorth AmericaUSCanadaEuropeGermanyItalyNetherlandsUKAsiaAustraliaChinaJapanSouth KoreaRest of World (ROW)

By Product Insights

The implantable neurostimulation devices segment is estimated to witness significant growth during the forecast period.Neurostimulation devices, a type of implantable medical technology, function as programmable and electrically stimulating medical tools for the central nervous system (CNS). These neurostimulators are utilized to stimulate specific areas of the peripheral nerve, spinal cord, or brain, offering relief from various neurological disorders and chronic pain. Notable neurostimulation therapies include spinal cord stimulation (SCS), sacral nerve stimulation (SNS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), gastric electric stimulation (GES), and peripheral nerve stimulation (PNS). SCS, also known as dorsal column stimulation (DCS,) involves the use of a small spinal cord stimulator to deliver low-voltage electrical current continuously to the spinal cord or specific nerves, thereby blocking pain signals from reaching the brain. Neurological conditions treated with neurostimulation devices encompass essential tremors, arthritis, Parkinson's, dystonia, migraine, depression, chronic pain, nerve injuries, osteoarthritis, and other neurovascular disorders. The regulatory approval process for these devices is rigorous to ensure safety and efficacy. Neurostimulation devices offer an alternative to invasive procedures and drug therapies, making them an essential tool for health

Neurostimulation Devices Market will grow from USD 8.06 Billion to USD 23.63 Billion by 2034, showing an impressive CAGR of 12.7%.

Explore Market Research Intellect's Neurostimulation Devices Market Report, valued at USD 9.5 billion in 2024, with a projected market growth to USD 16.8 billion by 2033, and a CAGR of 7.8% from 2026 to 2033.

Global Neurostimulation Devices market size earned around $6.48 Bn in 2023 and is expected to reach $18.71 Bn by 2032, with a projected CAGR of 12.5%.

Neurostimulation Devices Market size, Neurostimulation Devices Market share, analysis by technology, application opportunity and growth.

The market is projected to reach USD 7.4 Billion by 2025 and USD 17.9 Billion by 2035, growing at a CAGR of 9.2% during the forecast period.

Country-wise outlook

Competitive Outlook

The Europe Neurostimulation Market is Segmented by Technology, Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Other Applications), and Geography.

Neurostimulation Devices Market Outlook

The global neurostimulation devices market size was valued at approximately USD 7.5 billion in 2023 and is projected to reach around USD 14.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.8% over the forecast period. Factors such as the increasing prevalence of chronic pain, neurological disorders, and a growing aging population are driving the growth of the neurostimulation devices market. Additionally, technological advancements and increasing demand for minimally invasive treatments contribute significantly to the market expansion.

The growth of the neurostimulation devices market is significantly driven by the rising incidence of chronic pain conditions and neurological disorders worldwide. Conditions such as Parkinson’s disease, epilepsy, and chronic back pain are becoming more prevalent with the aging population, necessitating effective treatment options. Neurostimulation devices offer a promising solution by modulating the nervous system to alleviate pain and manage symptoms. This increased demand for effective pain management solutions is propelling the market forward.

Technological advancements in neurostimulation devices are another key growth driver. Continuous research and development efforts are leading to innovations such as more compact, efficient, and user-friendly devices. Enhanced battery life, improved targeting accuracy, and the ability to adjust stimulation parameters remotely are some of the advancements that are making these devices more appealing to both patients and healthcare providers. The integration of wireless technology and the development of closed-loop systems that provide real-time feedback are expected to further boost the adoption of neurostimulation devices.

Furthermore, the increasing preference for minimally invasive procedures is fueling the growth of the neurostimulation devices market. Patients are increasingly opting for treatments that offer quicker recovery times, minimal surgical risks, and reduced hospital stays. Neurostimulation devices, being minimally invasive, align well with these preferences. This shift towards less invasive treatment options is contributing to the rising adoption of neurostimulation therapies across various medical fields, including pain management and neurology.

Regionally, North America holds the largest share of the neurostimulation devices market, attributed to the high prevalence of chronic pain and neurological disorders, well-established healthcare infrastructure, and significant investments in research and development. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing healthcare expenditure, growing awareness about neurostimulation therapies, and a large patient pool suffering from chronic conditions. Governments in emerging economies like China and India are also taking initiatives to improve healthcare access, further boosting the market growth in this region.

Product Type Analysis

Spinal cord stimulators are among the most widely used neurostimulation devices, primarily utilized for managing chronic pain conditions such as failed back surgery syndrome, complex regional pain syndrome, and neuropathic pain. These devices work by delivering electrical pulses to the spinal cord, which interfere with the pain signals traveling to the brain. The demand for spinal cord stimulators is driven by their effectiveness in reducing pain, improving quality of life, and decreasing dependency on opioid medications. Continuous advancements in device technology, such as the development of rechargeable systems and improved lead designs, are further enhancing the adoption of spinal cord stimulators.

Deep brain stimulators (DBS) are increasingly employed for the treatment of movement disorders, including Parkinson’s disease, essential tremor, and dystonia. DBS involves the implantation of electrodes within specific areas of the brain, which are connected to a neurostimulator device that generates electrical impulses. These impulses help regulate abnormal brain activity, providing symptom relief for patients. The growing prevalence of Parkinson’s disease and other movement disorders, coupled with the limitations of pharmacological treatments, is driving the demand for deep brain stimulators. Additionally, ongoing research is exploring the potential of DBS for other psychiatric conditions, such as depression and obsessive-compulsive disorder (OCD).

Sacral nerve stimulators are primarily used for the treatment of urinary and

The global neurostimulation devices market may hit $11.18B by 2029, growing at 12%, driven by rising demand and an aging global population.

BCC Research Market Report says global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate of 7.4%.